Capital Fund Management (CFM)
PFE icon

Capital Fund Management (CFM)’s Pfizer PFE Stock Holding History

Capital Fund Management (CFM)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-264,357
Closed -$6.92M – 2312
2026
Q1 		$7.42M Buy
+264,357
New +$7.04M 0.03% 694
2025
Q4 		– Sell
-302,082
Closed -$7.62M – 2581
2025
Q3 		$7.7M Buy
302,082
+229,810
+318% +$5.67M 0.02% 990
2025
Q2 		$1.75M Sell
72,272
-87,155
-55% -$2.03M ﹤0.01% 1748
2025
Q1 		$4.04M Buy
159,427
+141,628
+796% +$3.71M 0.01% 1114
2024
Q4 		$472K Sell
17,799
-1,400,647
-99% -$38M ﹤0.01% 1918
2024
Q3 		$41M Sell
1,418,446
-260,592
-16% -$7.6M 0.11% 243
2024
Q2 		$47M Buy
1,679,038
+760,006
+83% +$20.9M 0.14% 203
2024
Q1 		$25.5M Sell
919,032
-311,253
-25% -$8.64M 0.07% 351
2023
Q4 		$35.4M Buy
1,230,285
+290,758
+31% +$8.79M 0.1% 296
2023
Q3 		$31.2M Buy
939,527
+284,697
+43% +$10.1M 0.11% 247
2023
Q2 		$24M Sell
654,830
-272,060
-29% -$10.6M 0.1% 285
2023
Q1 		$37.8M Buy
926,890
+565,239
+156% +$24.4M 0.18% 134
2022
Q4 		$18.5M Sell
361,651
-289,994
-45% -$13.9M 0.12% 222
2022
Q3 		$28.5M Buy
651,645
+617,731
+1,821% +$30M 0.22% 113
2022
Q2 		$1.78M Buy
+33,914
New +$1.73M 0.02% 878
2022
Q1 		– Sell
-13,317
Closed -$691K – 1713
2021
Q4 		$786K Sell
13,317
-32,758
-71% -$1.62M 0.01% 1348
2021
Q3 		$1.98M Sell
46,075
-63,791
-58% -$2.83M 0.01% 947
2021
Q2 		$4.3M Buy
+109,866
New +$4.27M 0.03% 621
2020
Q3 		– Sell
-56,817
Closed -$1.99M – 1346
2020
Q2 		$1.76M Sell
56,817
-323,864
-85% -$11M 0.03% 539
2020
Q1 		$11.8M Sell
380,681
-243,774
-39% -$8.31M 0.18% 160
2019
Q4 		$23.2M Sell
624,455
-120,999
-16% -$4.31M 0.18% 143
2019
Q3 		$25.4M Buy
745,454
+701,988
+1,615% +$25.5M 0.23% 116
2019
Q2 		$1.79M Buy
+43,466
New +$1.73M 0.02% 835
2018
Q1 		– Sell
-468,315
Closed -$16.1M – 2099
2017
Q4 		$16.1M Buy
468,315
+300,167
+179% +$10.2M 0.09% 274
2017
Q3 		$5.7M Sell
168,148
-224,782
-57% -$7.22M 0.04% 506
2017
Q2 		$12.5M Buy
+392,930
New +$12.4M 0.1% 259
2017
Q1 		– Sell
-1,257,051
Closed -$39.6M – 1736
2016
Q4 		$38.7M Buy
1,257,051
+926,760
+281% +$28.3M 0.33% 71
2016
Q3 		$10.6M Buy
+330,291
New +$11M 0.1% 252
2016
Q1 		– Sell
-1,129,231
Closed -$32.3M – 1778
2015
Q4 		$34.6M Buy
1,129,231
+1,045,552
+1,249% +$32.9M 0.36% 59
2015
Q3 		$2.49M Sell
83,679
-52,583
-39% -$1.69M 0.03% 554
2015
Q2 		$4.33M Buy
+136,262
New +$4.44M 0.06% 417
2014
Q4 		– Sell
-9,486
Closed -$272K – 1754
2014
Q3 		$266K Sell
9,486
-2,067,115
-100% -$58M ﹤0.01% 1363
2014
Q2 		$58.5M Buy
2,076,601
+1,953,824
+1,591% +$55.7M 0.62% 10
2014
Q1 		$3.74M Sell
122,777
-106,437
-46% -$3.17M 0.05% 464
2013
Q4 		$6.66M Buy
+229,214
New +$6.67M 0.08% 301

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital Fund Management (CFM)'s PFE Position: Q2 2026 in Review

Capital Fund Management (CFM) sold out of Pfizer (PFE) in Q2 2026, closing a stake of 264,357 shares — an estimated $6.92M sold.

Capital Fund Management (CFM) first reported a position in PFE in Q4 2013 and held it in 35 quarters. The position peaked at $58.5M in Q2 2014. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Capital Fund Management (CFM) reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 264,357 Pfizer shares in Q2 2026, an estimated $6.92M.
  • Capital Fund Management (CFM) first reported a position in Pfizer in Q4 2013 and held it in 35 quarters.
  • Capital Fund Management (CFM)'s Pfizer position peaked at $58.5M in Q2 2014.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.